Arterial endothelial dysfunction and idiopathic deep venous thrombosis

Journal of Biological Regulators and Homeostatic Agents

Volumn 25, Issue 4, 2011, Pages 565-573

  Mazzoccoli, Gianluigi ^a   Grilli, M ^a   Ferrandino, F ^a   Copetti, M ^a   Fontana, A ^a   Pellegrini, F ^a,b   Dagostino, M P ^a   De Cata, A ^a   Vendemiale, G ^a,c  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Consorzio Mario Negri Sud ^*  (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Atherosclerosis; Endothelial dysfunction; Flow mediated dilation; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ARTERY ENDOTHELIUM; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DRUG USE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY;

ADULT; AGED; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; VASODILATION; VENOUS THROMBOSIS;

EID: 84856018967     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 349:1435-41. (Pubitemid 36407172)
2. Jezovnik MK, Poredos P, Lusa. Idiopathic venous thrombosis is associated with preclinical atherosclerosis. J Atheroscler Thromb 2010; 17:304-11.
3. Prandoni P, Ghirarduzzi A, Prins MH, et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost 2006; 4:1891-96. (Pubitemid 44226764)
4. Prandoni P. Venous thromboembolism and atherosclerosis: is there a link? J Thromb Haemost 2007; 5:270-75. (Pubitemid 46958842)
5. Jezovnik MK, Poredos P, Stalc M. Impairment of the vasodilatation capability of the brachial artery in patients with idiopathic venous thrombosis. J Atheroscler Thromb 2010; 17:1190-98.
6. Glynn RJ, Danielson E, Fonseca FA, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009; 360:1851-61.
7. Lahera V, Goicoechea M, de Vinuesa SG, et al. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr Med Chem 2007; 14:243-48. (Pubitemid 46043919)
8. Ito MK, Talbert RL, Tsimikas S. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction. Pharmacotherapy 2006; 26:85S-97S. (Pubitemid 43993553)
9. Saini HK, Xu YJ, Arneja AS, et al. Pharmacological basis of different targets for the treatment of atherosclerosis. J Cell Mol Med 2005; 9:818-39. (Pubitemid 43116549)
10. Holst AG, Jensen G, Prescott E. Risk Factors for Venous Thromboembolism Results From the Copenhagen City Heart Study. Circulation 2010; 121:1896-903.
11. Takase B, Uehata A, Akima T, et al. Endothelium-dependent flow mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 1998; 82:1535-39. (Pubitemid 29006482)
12. Ageno W, Becattini C, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117:93-102. (Pubitemid 350301144)
13. Sørensen HT, Horvath-Puho E, Pedersen L, et al. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007; 370:1773-79. (Pubitemid 350137491)
14. Tsai AW, Cushman M, Rosamond WD, et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002; 162:1182-89. (Pubitemid 34522408)
15. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008; 28:370-72.
16. Isma N, Svensson PJ, Gottsäter A, et al. Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS). Thromb Res 2009; 124:663-66.
17. Jezovnik MK, Poredos P, Lusa L. Idiopathic venous thrombosis is associated with preclinical atherosclerosis. J Atheroscler Thromb 2010; 17:304-11.
18. Borch KH, Braekkan SK, Mathiesen EB, et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromso study. J Thromb Haemost 2009; 7:739-45.
19. Steffen LM, Cushman M, Peacock JM, et al. Metabolic syndrome and risk of venous thromboembolism: longitudinal investigation of thromboembolism Etiology. J Thromb Haemost 2009; 7:746-51.
20. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome Am J Pathol 2008; 173:1210-19.
21. Van der Hagen PB, Folsom AR, Jenny NS, et al. Subclinical atherosclerosis and the risk of future venous thrombosis in the cardiovascular health study. J Thromb Haemost 2006; 4:1903-8. (Pubitemid 44226766)
22. Reich LM, Folsom AR, Key NS, et al. Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost 2006; 4:1909-13. (Pubitemid 44226767)
23. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force. JACC 2002; 39:257-65. (Pubitemid 34084631)
24. Bots ML, Westerink J, Rabelink TJ, et al. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J 2005; 26:363-68. (Pubitemid 40283095)
25. Peretz A, Leotta DF, Sullivan JH, et al. Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization. BMC Cardiovasc Disord 2007; 7:11-19.
26. Roman MJ, Naqvi TZ, Gardin JM, et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 2006; 19:943-54. (Pubitemid 44118704)
27. Matsuo S, Matsumoto T, Takashima H, et al. The relationship between flow-mediated brachial artery vasodilation and coronary vasomotor responses to bradykinin: comparison with those to acetylcholine. J Cardiovasc Pharmacol 2004; 44:164-70. (Pubitemid 38982158)
28. Smeeth L, Cook C, Thomas S, et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006; 367:1075-79.
29. Eriksson EE, Karlof E, Lundmark K, et al. Powerful inflammatory properties of large vein endothelium in vivo. Arterioscler Thromb Vasc Biol 2005; 25:723-28. (Pubitemid 40463860)
30. Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005; 45:1467-71. (Pubitemid 40615620)
31. Thanyasiri P, Celermajer DS, Adams MR. Endothelial dysfunction occurs in peripheral circulation patients with acute and stable coronary artery disease. Am J Physiol Heart Circ Physiol 2005; 289:H513-H17.
32. Gresele P, Momi S, Migliacci R. Endothelium, venous thromboembolism and ischaemic cardiovascular events. Thromb Haemost 2010; 103:56-61.
33. Migliacci R, Becattini C, Pesavento R, et al. Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica 2007; 92:812-18. (Pubitemid 350155307)
34. Agnelli G, Becattini C. Venous thromboembolism and atherosclerosis: common denominators or different diseases? J Thromb Haemost 2006; 4:1886-90. (Pubitemid 44226763)
35. Teragawa H, Kato M, Kurokawa J, et al. Usefulness of flow-mediated dilation of the brachial artery and/ or the intima-media thickness of the carotid artery in predicting coronary narrowing in patients suspected of having coronary artery disease. Am J Cardiol 2001; 88:1147-51. (Pubitemid 33043848)